File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0024505819
- PMID: 2709336
- WOS: WOS:A1989U279300009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Differential inhibition by ergonovine of norepinephrine release in the coronary artery and saphenous vein of the dog
Title | Differential inhibition by ergonovine of norepinephrine release in the coronary artery and saphenous vein of the dog |
---|---|
Authors | |
Issue Date | 1989 |
Publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org |
Citation | Journal Of Pharmacology And Experimental Therapeutics, 1989, v. 249 n. 1, p. 52-55 How to Cite? |
Abstract | Experiments were performed to determine the effect of ergonovine on adrenergic neurotransmission in the blood vessel wall. Strips of canine left circumflex coronary arteries and saphenous veins were incubated with [3H]norepinephrine and suspended for superfusion. Ergonovine (10-6 M) decreased the overflow of [3H]norepinephrine to a modest degree in the coronary artery, whereas a profound inhibition of overflow was observed in the saphenous vein. Methiothepin, but not rauwolscine, reversed the inhibitory effect of ergonovine in both blood vessels. Treatment with atropine or droperidol did not alter the response to ergonovine in the coronary artery. The results demonstrate that ergonovine, by activating prejunctional serotonergic receptors, inhibits adrenergic neurotransmission to a greater extent in the saphenous vein than in the coronary artery. The differential effect of ergonovine on norepinephrine release in these vessels may provide evidence for heterogeneity in the prejunctional modulation of adrenergic neurotransmission. |
Persistent Identifier | http://hdl.handle.net/10722/170950 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.829 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | O'rourke, ST | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:11:34Z | - |
dc.date.available | 2012-10-30T06:11:34Z | - |
dc.date.issued | 1989 | en_US |
dc.identifier.citation | Journal Of Pharmacology And Experimental Therapeutics, 1989, v. 249 n. 1, p. 52-55 | en_US |
dc.identifier.issn | 0022-3565 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170950 | - |
dc.description.abstract | Experiments were performed to determine the effect of ergonovine on adrenergic neurotransmission in the blood vessel wall. Strips of canine left circumflex coronary arteries and saphenous veins were incubated with [3H]norepinephrine and suspended for superfusion. Ergonovine (10-6 M) decreased the overflow of [3H]norepinephrine to a modest degree in the coronary artery, whereas a profound inhibition of overflow was observed in the saphenous vein. Methiothepin, but not rauwolscine, reversed the inhibitory effect of ergonovine in both blood vessels. Treatment with atropine or droperidol did not alter the response to ergonovine in the coronary artery. The results demonstrate that ergonovine, by activating prejunctional serotonergic receptors, inhibits adrenergic neurotransmission to a greater extent in the saphenous vein than in the coronary artery. The differential effect of ergonovine on norepinephrine release in these vessels may provide evidence for heterogeneity in the prejunctional modulation of adrenergic neurotransmission. | en_US |
dc.language | eng | en_US |
dc.publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org | en_US |
dc.relation.ispartof | Journal of Pharmacology and Experimental Therapeutics | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Coronary Vessels - Drug Effects - Secretion | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Ergonovine - Pharmacology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Norepinephrine - Secretion | en_US |
dc.subject.mesh | Perfusion | en_US |
dc.subject.mesh | Receptors, Serotonin - Drug Effects | en_US |
dc.subject.mesh | Saphenous Vein - Drug Effects - Secretion | en_US |
dc.title | Differential inhibition by ergonovine of norepinephrine release in the coronary artery and saphenous vein of the dog | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 2709336 | - |
dc.identifier.scopus | eid_2-s2.0-0024505819 | en_US |
dc.identifier.volume | 249 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 52 | en_US |
dc.identifier.epage | 55 | en_US |
dc.identifier.isi | WOS:A1989U279300009 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | O'Rourke, ST=7005313078 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0022-3565 | - |